Prof Mark Rosenthal
Honorary (Professorial Fellow)
The Sir Peter MacCallum Department of Oncology
259 Scholarly works
7 Projects
HIGHLIGHTS
2025
Journal article
Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial
DOI: 10.1038/s41591-025-03884-42023
Journal article
Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26
DOI: 10.1093/neuonc/noac2792022
Research grants (other domestic)
The COMET (Community Supportive Care Trials) Program: Enhancing Supportive Care Trials for Community Dwelling People With Cancer
2022
Research Grant
The COMET (Community Supportive Care Trials) Program: Enhancing Supportive Care Trials For Community Dwelling People With Cancer
2021
Research grants (ARC, NHMRC, MRFF)
Targeted Therapies for Vascular Malformations
2019
Journal article
A phase Ib dose-escalation and expansion study of the BCL2 inhibitor venetoclax combined with tamoxifen in ER and BCL2– positive metastatic breast cancer
DOI: 10.1158/2159-8290.CD-18-11512012
Journal article
Glutamate is associated with a higher risk of seizures in patients with gliomas
DOI: 10.1212/WNL.0b013e318266fa89
RECENT SCHOLARLY WORKS
2026
Journal article
Automated imaging response evaluation system: Prototype software tool for standardized radiographic response assessment in glioblastoma clinical trials
DOI: 10.1093/nop/npag0392025
Journal article
First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastoma
DOI: 10.1093/noajnl/vdaf1602024
Journal article
A PERIOPERATIVE STUDY OF SAFUSIDENIB IN PATIENTS WITH IDH1 MUTATED GLIOMA
DOI: 10.1093/neuonc/noae165.03822024
Journal article
443O A perioperative study of safusidenib in patients with IDH1 mutated glioma
DOI: 10.1016/j.annonc.2024.08.5132024
Journal article
361P PALVEN: A phase Ib study of palbociclib, letrozole and venetoclax in ER and BCL2-positive metastatic breast cancer
DOI: 10.1016/j.annonc.2024.08.3092024
Journal article
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)
DOI: 10.1007/s11060-024-04668-52024
Journal article
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma
DOI: 10.1007/s11060-023-04513-12024
Journal article
A perioperative study of Safusidenib in patients with IDH1-mutated glioma
DOI: 10.1080/14796694.2024.2383064